Epidermal growth factor receptor - Immunohistochemical detection and clinical significance for treatment of primary breast cancer

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2799-2802

  Schroeder, Willibald ^a   Biesterfeld, S ^a   Zillessen, S ^a   Rath, W ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Breast cancer; Epidermal growth factor receptor; Immunohistochemical assay; Treatment options

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PEROXIDASE; STREPTAVIDIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METHODOLOGY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030748009     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Normanno N, Ciardiello F, Brandt R, Salomon DS: Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res Treat 29: 11-27, 1994.
2. Stoschek CM, King jr. LE: Role of Epidermal Growth Factor in Carcinogenesis Cancer Res 46: 1030-1037, 1986.
3. Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer Lancet I: 1398-1402, 1987.
4. Harris AL: Epidermal Growth Factor Receptor in Human Breast Cancer Recent Results in Cancer Research Vol. 113, 70-77 Springer Berlin Heidelberg 1989
5. KJijn IGM, Berns PMII, Schmitz PIM, Foekens JA: The clinical significance of Epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients Endocr Rev 13: 3-17, 1992.
6. Beckmann MW, Stegmüller M, Niederacher D, Tutschek B, Schnaeurch HG, Bender HG: Modification of the Routine Biochemical Analysis of the Epidermal Growth Factor Receptor (EGF-R) on Breast Tumor Specimens Tumordiagn, u. Ther. (1993) 14: 41-48, 1993.
7. Fox SB, Smith K, Hollyer I, Greenall M, Hastrich D, Harris AL: The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients Breast Cancer Res Treat 29: 41-49, 1994.
8. Remmele W, Stegner HE: Vorschlag zur einheitlichen Definition eines Immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe Pathologe 8: 138-140, 1987.
9. Sainsbury JRC, Farndon JR, Sherbet VG, Harris AL: Epidermal growth factor receptors and oestrogen receptors in human breast cancer Lancet 364-366, 1985.
10. Newby JC, Ahern RP, Leek RD, Smith IE, Harris AL, Dowsett M: Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer Br J Cancer 71: 1237-1242, 1995.
11. Klijn IGM, Look MP, Portengen H, Alexiena-Figusch I, Van Putten WLJ, Foekens JA: The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study Breast Cancer Res Treat 29: 73-83, 1994.
12. Toi M, Tominaga T, Osaki A, Toge T: Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical and immuno-cytochemical study Breast Cancer Res Treat 29: 51-58, 1994.
13. Nicholson S, Wright C, Sainsbury JRC, Halcrow P, Kelly P, Angus B, Farndon JR, Harris AL: Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: new and tamoxifen failure J Steroid Biochem Molec Biol 37: 811-814, 1990.
14. Schönborn J, Mingullon C, Lichtenegger W, Zschiesche W, Spitzer E: C-erbB-2, EGF-Rezeptor, p53 und PCNA. Die prognostische Bedeutung neuer Faktoren für das Lymphknoten-negative Mammakarzinom Geburtsh. u. Frauenheilk 55: 566-571, 1995.
15. Koenders PG, Beex Lvam, Kienhuis CBM, Kloppenborg PWC, Benraad TJ: Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study Breast Cancer Res Treat 25: 21-27, 1993.
16. Spyratos F, Martin PM, Hacène K, Andrieu C, Romain S, Floiras JL, Magdelénat H: Prognostic value of a solubilized fraction of EGF receptor in primary breast cancer using an immunoenzymatic assay- a retrospective study Breast Cancer Res Treat 29: 85-95, 1994.
17. Rallet A, Faroux MJ, Theobald S, Caquot LM, Pourny C, Pluot M, Jardiilier JC: Epidermal Growth Factor Receptors in Breast Cancer: Comparison of Radioligand and Immunocytochemical Assay Anticancer Res 14: 1417-1422, 1994.
18. Diez-Gilbert O, Fernández-Montoli ME, Nácher V, Navarro MA: Estimation of the Epidermal Growth Factor Receptor by the Hydroxyapatite Method in Human Breast Cancer Eur J Clin Chem Clin Biochem 33 (9): 563-568, 1995.
19. Iwase H, Kobayshi S, Itoh Y, Kuzushima T, Yamashita H, Iwata H, NaitoO A, Yamashita T, Itoh K, Masaoka A: Clinical value of enzyme immunoassay of epidermal growth factor receptor in human breast cancer Breast Cancer Res Treat 28: 215-221, 1993.
20. Koenders PG, Faverly D, Beex Lvam, Bruggink EDM, Kienhuis CBM, Benraad TJ: Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology Eur J Cancer 28: 693-697, 1992.
21. Dittadi R, PM Donisi, Brazzale A, Cappeloza L, Bruscagnin G, Gion M: Epidermal growth factor receptor in breast cancer. Comparison with non malignant tissue Br J Cancer 67: 7-9, 1993.
22. Barker S, Panahy C, Puddefoot JR. Goode AW, Vinson GP: Epidermal growth factor receptor and oestrogen receptors in the nonmalignant part of the cancerous breast Br J Cancer 60: 673-677, 1989.
23. Travers M, Barrett-Lee P, Berger V, Luqmani Y, Gazet JC, Powles TJ, Coombes RC: Growth factor expression in normal, benign and malignant breast tissue Br Med J 296: 1621-1624, 1988.
24. Toi M, Hamada Y, Nakamura T, Mukaida H, Sushiro S, Wada T, Toge T, Numoto M, Hattori T: Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion Int J Cancer 43: 220-225, 1989.
25. Chrysogelos SA, Dickson RB: EOF receptor expression, regulation and function in breast cancer Breast Cancer Res Treat 29: 29-40, 1994.
26. Nicholson RI, Me Clelland RA, Gee IMW, Manning OL, Cannon P, Robertson IFR, Ellis IO, Blarney RW: Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy Breast Cancer Res Treat 29: 117-125, 1994.
27. Miller DL, El-Ashry D, Cheville AL, Liu Y, McLesskey SW, Kern FG: Emergence of MCF-7 Cells Overexpressing a Transfected Epidermal Growth Factor Receptor (EGFR) under Estrogen-depleted Conditions: Evidence for a Role of EGFR in Breast Cancer Growth and Progression. Cell Growth & Differentiation 5: 1263-1274, 1994.
28. Lupu R, Cardillo M, Harris L, Hijazi M, Rosenberg K: Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance Seminars in Cancer Biology 6: 135-145, 1995.
29. Schnürch HG, Stegmüller M, Vering A, Beckmann MW, Bender HG: Growth Inhibition of Xenotransplanted Human Carcinomas by a Monoclonal Antibody Directed Against the Epidermal Growth Factor Receptor Eur J Cancer 30: 491-496, 1994.
30. Mishra S, Ham AW: Association of inhibition of cell growth by Ophospho-L-tyrosine with decreased tyrosine phosphorylation Cancer Letters 102: 65-71, 1996.
31. Baselga J, Mendelsohn J: The epidermal growth factor receptor as a target for therapy in breast carcinoma Breast Cancer Res Treat 29: 127-138, 1994.